Dr. Haijun Zhong 钟海均
Chief Physician
Department of Medical Oncology for Colorectal Cancer, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis, treatment, and research of gastrointestinal tumors, including gastric cancer, colorectal cancer, gallbladder cancer, and pancreatic cancer.
Dr. Zhong is Chief Physician and Director of the Abdominal Tumor Internal Medicine Department at Zhejiang Cancer Hospital. A 1991 graduate of Wenzhou Medical College, Dr. Zhong specializes in chemotherapy for abdominal malignancies. Research includes exosomes from heat-treated gastric cancer ascites. Dr. Zhong received the Third Prize of the Zhejiang Natural Science Academic Award in 2010.
Professional roles
- Member and Secretary, Chemotherapy Professional Committee, China Anti-Cancer Association
- Member, Zhejiang Province Tumor Diagnosis and Treatment Quality Control Chemotherapy Professional Group
Name order: in Chinese the family name comes first (Zhong Haijun). Papers usually list the name as Haijun Zhong or Zhong H.
Selected publications
46 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Pharmacol, 2021 (senior author): Cetuximab Can Be an Effective and Low-Toxicity Maintenance Treatment Drug in Patients With Metastatic Colorectal Cancer: A Real-World Study of Zhejiang Cancer Hospital. PubMed 34122063
- Sci Rep, 2019 (senior author): Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells. PubMed 30824833
- Saudi J Gastroenterol, 2019 (senior author): Circular RNA ARHGAP26 is over-expressed and its downregulation inhibits cell proliferation and promotes cell apoptosis in gastric cancer cells. PubMed 30719998
- Mol Clin Oncol, 2017 (senior author): The significance of multi-line chemotherapy for advanced gastric cancer: A retrospective analysis. PubMed 28413678
- Mol Clin Oncol, 2016 (senior author): A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. PubMed 27446587
- PLoS One, 2015 (senior author): Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin. PubMed 25992623
- Int J Hyperthermia, 2015 (senior author): Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress. PubMed 25955015
- J Cancer Res Ther, 2014 (senior author): High levels of D-dimer correlated with disease status and poor prognosis of inoperable metastatic colorectal cancer patients treated with bevacizumab. PubMed 25693928
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion